Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Brentuximab vedotin a kombinovaná chemoterapie v léčbě dětí a mladých dospělých s Hodgkinovým lymfomem stadia IIB, stadia IIIB, IVA nebo IVB

10. listopadu 2026 aktualizováno: National Cancer Institute (NCI)

Randomizovaná studie fáze 3 Brentuximab vedotinu (SGN-35) pro nově diagnostikovaný vysoce rizikový klasický Hodgkinův lymfom (cHL) u dětí a mladých dospělých

This phase III trial studies brentuximab vedotin and combination chemotherapy to see how well they work compared to combination chemotherapy alone in treating children and young adults with stage IIB with bulk, stage IIIB, IVA, or IVB Hodgkin lymphoma. Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Chemotherapy drugs, such as doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known if combination chemotherapy is more effective with or without brentuximab vedotin in treating children with high-risk Hodgkin lymphoma.

Přehled studie

Detailní popis

PRIMARY OBJECTIVE:

I. To assess the event free survival (EFS) of a novel regimen incorporating brentuximab vedotin (Bv; Adcetris) in the chemotherapy backbone of doxorubicin hydrochloride (doxorubicin) (Adriamycin), vincristine sulfate (vincristine), etoposide, prednisone and cyclophosphamide (Bv-AVEPC) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) compared to those treated with Adriamycin, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC).

SECONDARY OBJECTIVES:

I. To determine whether children/young adults with high-risk cHL treated with Bv-AVEPC have a higher rate of early response (determined by fludeoxyglucose F 18 [FDG]-positron emission tomography [PET]) and a reduction in protocol directed radiation therapy (RT) compared to those treated with ABVE-PC.

II. To compare the rate of neuropathy (>= grade 3) among patients treated on the Bv-AVEPC (experimental arm) to patients treated on the ABVE-PC (standard arm).

EXPLORATORY OBJECTIVES:

I. To validate and compare the Childhood Hodgkin International Prognostic Score (CHIPS) to conventional Ann Arbor stage (stages II B with bulk, III B, IV A or B) in predicting outcome in high-risk childhood cHL.

II. To determine the incidence of preferentially expressed antigen in melanoma (PRAME) and testis-specific antigens in Epstein-Barr virus (EBV)- cHL tumors and the incidence of EBV antigens (Epstein-Barr nuclear antigen 1 [EBNA1], Epstein-Barr virus latent membrane protein 1 [LMP1], large multifunctional peptidase 2 [LMP2]) in EBV+ cHL tumors, with the goal of developing strategies to integrate cellular therapy into treatment for newly diagnosed high-risk cHL. (Biology) III. To incorporate qualitative visual FDG-PET into response-directed treatment algorithms and explore quantitative FDG-PET and computed tomography (CT) definitions of tumor burden and response for incorporation into next generation pediatric cHL risk-stratification schemes, exploring the extension of these algorithms to young adults. (Imaging) IV. To evaluate the reduction in normal tissue irradiation associated with the current treatment approach compared to the volume of historic involved field radiation therapy (IFRT) fields. (Radiation Therapy) V. To evaluate EFS and patterns of relapse following protocol-specified RT utilization and treatment volumes. (Radiation Therapy) VI. To characterize the extent of chemotherapy induced peripheral neuropathy (CIPN), as reported by patients and parent proxies, through serial administration of the Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity (FACT-GOG-NTX). (Patient Reported Outcomes [PRO] of Peripheral Neuropathy and Health-Related Quality of Life) VII. To describe the Health-Related Quality of Life (HRQL) consequences of peripheral neuropathy over time by correlating total neuropathy scale scores with the individual items with the Child Health Ratings Inventories (CHRIs)-Global scale (e.g., physical health, pain, emotional functioning). (PRO of Peripheral Neuropathy and Health-Related Quality of Life) VIII. To perform a cross validation of the FACT-GOG-NTX with the Total Neuropathy Score-Pediatric Vincristine (TNS-PV) to determine the performance of both measures with the use of brentuximab vedotin in a limited institutional approach in children and adolescents with cHL. (PRO of Peripheral Neuropathy and Health-Related Quality of Life) IX. To assess the resource use and cost implications of Bv in combination with chemotherapy and radiotherapy (RT) for newly diagnosed high-risk cHL in children and young adults. (Economic) X. To estimate the risk of relapse among rapidly responding lesions (RRL) subjects that have at least one lesion that is Deauville 3 at PET 2. (Follow-up of Deauville score 3 lesions on FDG-PET imaging [confirmed by central imaging review]) XI. To characterize the pharmacokinetics of brentuximab vedotin in children < 13 years of age.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I (ABVE-PC): Patients receive doxorubicin hydrochloride intravenously (IV) over on days 1-2, bleomycin sulfate IV or subcutaneously (SC) on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally (PO) twice daily (BID) or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2.

ARM II (Bv-AVEPC): Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8.

In both arms, treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity. Granulocyte simulating factor (GCSF) or equivalent is given on both arms.

After completion of study treatment, patients are followed up at 3, 6, 9, 12, 18, 24, 30, 36, and 48 months.

Typ studie

Intervenční

Zápis (Aktuální)

600

Fáze

  • Fáze 3

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

      • Québec, Kanada, G1V 4G2
        • CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
    • Alberta
      • Calgary, Alberta, Kanada, T3B 6A8
        • Alberta Children's Hospital
      • Edmonton, Alberta, Kanada, T6G 2B7
        • University of Alberta Hospital
    • British Columbia
      • Vancouver, British Columbia, Kanada, V6H 3V4
        • British Columbia Children's Hospital
    • Manitoba
      • Winnipeg, Manitoba, Kanada, R3E 0V9
        • CancerCare Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada, B3K 6R8
        • IWK Health Centre
    • Ontario
      • Hamilton, Ontario, Kanada, L8N 3Z5
        • McMaster Children's Hospital at Hamilton Health Sciences
      • Kingston, Ontario, Kanada, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Kanada, N6A 5W9
        • Children's Hospital
      • Ottawa, Ontario, Kanada, K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Toronto, Ontario, Kanada, M5G 1X8
        • Hospital for Sick Children
    • Quebec
      • Montreal, Quebec, Kanada, H3H 1P3
        • The Montreal Children's Hospital of the MUHC
      • Montreal, Quebec, Kanada, H3T 1C5
        • Centre Hospitalier Universitaire Sainte-Justine
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada, S7N 4H4
        • Saskatoon Cancer Centre
      • Caguas, Portoriko, 00726
        • HIMA San Pablo Oncologic Hospital
      • San Juan, Portoriko, 00926
        • University Pediatric Hospital
      • San Juan, Portoriko, 00912
        • San Jorge Children's Hospital
    • Alabama
      • Birmingham, Alabama, Spojené státy, 35233
        • Children's Hospital of Alabama
      • Mobile, Alabama, Spojené státy, 36604
        • USA Health Strada Patient Care Center
    • Alaska
      • Anchorage, Alaska, Spojené státy, 99508
        • Providence Alaska Medical Center
    • Arizona
      • Mesa, Arizona, Spojené státy, 85202
        • Banner Children's at Desert
      • Phoenix, Arizona, Spojené státy, 85016
        • Phoenix Childrens Hospital
      • Tucson, Arizona, Spojené státy, 85719
        • Banner University Medical Center - Tucson
    • Arkansas
      • Little Rock, Arkansas, Spojené státy, 72202-3591
        • Arkansas Children's Hospital
    • California
      • Downey, California, Spojené státy, 90242
        • Kaiser Permanente Downey Medical Center
      • Duarte, California, Spojené státy, 91010
        • City of Hope Comprehensive Cancer Center
      • Loma Linda, California, Spojené státy, 92354
        • Loma Linda University Medical Center
      • Long Beach, California, Spojené státy, 90806
        • Miller Children's and Women's Hospital Long Beach
      • Los Angeles, California, Spojené státy, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Spojené státy, 90027
        • Children's Hospital Los Angeles
      • Madera, California, Spojené státy, 93636
        • Valley Children's Hospital
      • Oakland, California, Spojené státy, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Spojené státy, 92868
        • Children's Hospital of Orange County
      • Sacramento, California, Spojené státy, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Spojené státy, 95817
        • University of California Davis Comprehensive Cancer Center
      • San Diego, California, Spojené státy, 92123
        • Rady Children's Hospital - San Diego
      • San Diego, California, Spojené státy, 92134
        • Naval Medical Center -San Diego
      • Santa Barbara, California, Spojené státy, 93102
        • Santa Barbara Cottage Hospital
      • Torrance, California, Spojené státy, 90502
        • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    • Colorado
      • Aurora, Colorado, Spojené státy, 80045
        • Children's Hospital Colorado
      • Denver, Colorado, Spojené státy, 80218
        • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    • Connecticut
      • Hartford, Connecticut, Spojené státy, 06106
        • Connecticut Children's Medical Center
      • New Haven, Connecticut, Spojené státy, 06520
        • Yale University
    • Delaware
      • Wilmington, Delaware, Spojené státy, 19803
        • Alfred I duPont Hospital for Children
    • District of Columbia
      • Washington D.C., District of Columbia, Spojené státy, 20010
        • Children's National Medical Center
      • Washington D.C., District of Columbia, Spojené státy, 20007
        • MedStar Georgetown University Hospital
    • Florida
      • Fort Lauderdale, Florida, Spojené státy, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Spojené státy, 33908
        • Golisano Children's Hospital of Southwest Florida
      • Gainesville, Florida, Spojené státy, 32610
        • UF Health Cancer Institute - Gainesville
      • Hollywood, Florida, Spojené státy, 33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville, Florida, Spojené státy, 32207
        • Nemours Children's Clinic-Jacksonville
      • Miami, Florida, Spojené státy, 33155
        • Nicklaus Children's Hospital
      • Miami, Florida, Spojené státy, 33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami, Florida, Spojené státy, 33176
        • Miami Cancer Institute
      • Orlando, Florida, Spojené státy, 32827
        • Nemours Children's Hospital
      • Orlando, Florida, Spojené státy, 32803
        • AdventHealth Orlando
      • Orlando, Florida, Spojené státy, 32806
        • Arnold Palmer Hospital for Children
      • Pensacola, Florida, Spojené státy, 32504
        • Nemours Children's Clinic - Pensacola
      • St. Petersburg, Florida, Spojené státy, 33701
        • Johns Hopkins All Children's Hospital
      • Tampa, Florida, Spojené státy, 33606
        • Tampa General Hospital
      • Tampa, Florida, Spojené státy, 33607
        • Saint Joseph's Hospital/Children's Hospital-Tampa
      • West Palm Beach, Florida, Spojené státy, 33407
        • Saint Mary's Medical Center
    • Georgia
      • Atlanta, Georgia, Spojené státy, 30329
        • Children's Healthcare of Atlanta - Arthur M Blank Hospital
      • Augusta, Georgia, Spojené státy, 30912
        • Augusta University Medical Center
      • Savannah, Georgia, Spojené státy, 31404
        • Memorial Health University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Spojené státy, 96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise, Idaho, Spojené státy, 83712
        • Saint Luke's Cancer Institute - Boise
    • Illinois
      • Chicago, Illinois, Spojené státy, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Spojené státy, 60612
        • University of Illinois
      • Chicago, Illinois, Spojené státy, 60611
        • Lurie Children's Hospital-Chicago
      • Maywood, Illinois, Spojené státy, 60153
        • Loyola University Medical Center
      • Oak Lawn, Illinois, Spojené státy, 60453
        • Advocate Children's Hospital-Oak Lawn
      • Park Ridge, Illinois, Spojené státy, 60068
        • Advocate Children's Hospital-Park Ridge
      • Peoria, Illinois, Spojené státy, 61637
        • OSF Children's Hospital of Illinois
      • Springfield, Illinois, Spojené státy, 62702
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis, Indiana, Spojené státy, 46202
        • Riley Hospital for Children
      • Indianapolis, Indiana, Spojené státy, 46260
        • Ascension Saint Vincent Indianapolis Hospital
    • Iowa
      • Des Moines, Iowa, Spojené státy, 50309
        • Blank Children's Hospital
      • Iowa City, Iowa, Spojené státy, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kentucky
      • Lexington, Kentucky, Spojené státy, 40536
        • University of Kentucky/Markey Cancer Center
      • Louisville, Kentucky, Spojené státy, 40202
        • Norton Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Spojené státy, 70121
        • Ochsner Medical Center Jefferson
      • New Orleans, Louisiana, Spojené státy, 70118
        • Children's Hospital New Orleans
    • Maine
      • Bangor, Maine, Spojené státy, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Spojené státy, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Spojené státy, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Spojené státy, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Bethesda, Maryland, Spojené státy, 20889-5600
        • Walter Reed National Military Medical Center
    • Massachusetts
      • Boston, Massachusetts, Spojené státy, 02111
        • Tufts Children's Hospital
      • Springfield, Massachusetts, Spojené státy, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Spojené státy, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Spojené státy, 48109
        • C S Mott Children's Hospital
      • Detroit, Michigan, Spojené státy, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Spojené státy, 48236
        • Henry Ford Health Saint John Hospital
      • East Lansing, Michigan, Spojené státy, 48823
        • Michigan State University
      • Flint, Michigan, Spojené státy, 48503
        • Hurley Medical Center
      • Grand Rapids, Michigan, Spojené státy, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Kalamazoo, Michigan, Spojené státy, 49007
        • Bronson Methodist Hospital
      • Royal Oak, Michigan, Spojené státy, 48073
        • Corewell Health Children's
    • Minnesota
      • Minneapolis, Minnesota, Spojené státy, 55404
        • Children's Hospitals and Clinics of Minnesota - Minneapolis
      • Minneapolis, Minnesota, Spojené státy, 55455
        • University of Minnesota/Masonic Cancer Center
      • Rochester, Minnesota, Spojené státy, 55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson, Mississippi, Spojené státy, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Columbia, Missouri, Spojené státy, 65212
        • University of Missouri Children's Hospital
      • Kansas City, Missouri, Spojené státy, 64108
        • Children's Mercy Hospitals and Clinics
      • St Louis, Missouri, Spojené státy, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Spojené státy, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Spojené státy, 63104
        • Cardinal Glennon Children's Medical Center
    • Nebraska
      • Omaha, Nebraska, Spojené státy, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Spojené státy, 68114
        • Children's Hospital and Medical Center of Omaha
    • Nevada
      • Las Vegas, Nevada, Spojené státy, 89144
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, Spojené státy, 89109
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, Spojené státy, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Spojené státy, 89102
        • University Medical Center of Southern Nevada
    • New Hampshire
      • Lebanon, New Hampshire, Spojené státy, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Hackensack, New Jersey, Spojené státy, 07601
        • Hackensack University Medical Center
      • Morristown, New Jersey, Spojené státy, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Spojené státy, 08901
        • Saint Peter's University Hospital
      • New Brunswick, New Jersey, Spojené státy, 08903
        • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
      • Newark, New Jersey, Spojené státy, 07112
        • Newark Beth Israel Medical Center
      • Paterson, New Jersey, Spojené státy, 07503
        • Saint Joseph's Regional Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Spojené státy, 87106
        • University of New Mexico Cancer Center
    • New York
      • Albany, New York, Spojené státy, 12208
        • Albany Medical Center
      • Buffalo, New York, Spojené státy, 14263
        • Roswell Park Cancer Institute
      • Mineola, New York, Spojené státy, 11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park, New York, Spojené státy, 11040
        • The Steven and Alexandra Cohen Children's Medical Center of New York
      • New York, New York, Spojené státy, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Spojené státy, 10029
        • Mount Sinai Hospital
      • New York, New York, Spojené státy, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York, New York, Spojené státy, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Spojené státy, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Spojené státy, 14642
        • University of Rochester
      • Stony Brook, New York, Spojené státy, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Spojené státy, 13210
        • State University of New York Upstate Medical University
      • The Bronx, New York, Spojené státy, 10467
        • Montefiore Medical Center - Moses Campus
    • North Carolina
      • Asheville, North Carolina, Spojené státy, 28801
        • Mission Hospital
      • Chapel Hill, North Carolina, Spojené státy, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Spojené státy, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte, North Carolina, Spojené státy, 28204
        • Novant Health Presbyterian Medical Center
      • Durham, North Carolina, Spojené státy, 27710
        • Duke University Medical Center
      • Greenville, North Carolina, Spojené státy, 27834
        • East Carolina University
      • Winston-Salem, North Carolina, Spojené státy, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Fargo, North Dakota, Spojené státy, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Spojené státy, 44308
        • Children's Hospital Medical Center of Akron
      • Cincinnati, Ohio, Spojené státy, 45229
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Spojené státy, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Spojené státy, 44106
        • Rainbow Babies and Childrens Hospital
      • Columbus, Ohio, Spojené státy, 43205
        • Nationwide Children's Hospital
      • Dayton, Ohio, Spojené státy, 45404
        • Dayton Children's Hospital
      • Toledo, Ohio, Spojené státy, 43606
        • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Spojené státy, 73104
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Portland, Oregon, Spojené státy, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Spojené státy, 97227
        • Legacy Emanuel Children's Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Spojené státy, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Spojené státy, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Spojené státy, 17822
        • Geisinger Medical Center
      • Hershey, Pennsylvania, Spojené státy, 17033
        • Penn State Children's Hospital
      • Philadelphia, Pennsylvania, Spojené státy, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, Spojené státy, 19134
        • Saint Christopher's Hospital for Children
      • Pittsburgh, Pennsylvania, Spojené státy, 15224
        • Children's Hospital of Pittsburgh of UPMC
    • Rhode Island
      • Providence, Rhode Island, Spojené státy, 02903
        • Rhode Island Hospital
    • South Carolina
      • Charleston, South Carolina, Spojené státy, 29425
        • Medical University of South Carolina
      • Columbia, South Carolina, Spojené státy, 29203
        • Prisma Health Richland Hospital
      • Greenville, South Carolina, Spojené státy, 29605
        • BI-LO Charities Children's Cancer Center
    • South Dakota
      • Sioux Falls, South Dakota, Spojené státy, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
    • Tennessee
      • Chattanooga, Tennessee, Spojené státy, 37403
        • T C Thompson Children's Hospital
      • Knoxville, Tennessee, Spojené státy, 37916
        • East Tennessee Childrens Hospital
      • Nashville, Tennessee, Spojené státy, 37232
        • Vanderbilt University/Ingram Cancer Center
      • Nashville, Tennessee, Spojené státy, 37203
        • The Children's Hospital at TriStar Centennial
    • Texas
      • Austin, Texas, Spojené státy, 78723
        • Dell Children's Medical Center of Central Texas
      • Corpus Christi, Texas, Spojené státy, 78411
        • Driscoll Children's Hospital
      • Dallas, Texas, Spojené státy, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Dallas, Texas, Spojené státy, 75230
        • Medical City Dallas Hospital
      • El Paso, Texas, Spojené státy, 79905
        • El Paso Children's Hospital
      • Fort Worth, Texas, Spojené státy, 76104
        • Cook Children's Medical Center
      • Houston, Texas, Spojené státy, 77030
        • UT MD Anderson Cancer Center
      • Houston, Texas, Spojené státy, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Lubbock, Texas, Spojené státy, 79410
        • Covenant Children's Hospital
      • Lubbock, Texas, Spojené státy, 79415
        • UMC Cancer Center / UMC Health System
      • San Antonio, Texas, Spojené státy, 78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio, Texas, Spojené státy, 78207
        • Children's Hospital of San Antonio
      • San Antonio, Texas, Spojené státy, 78229
        • Methodist Children's Hospital of South Texas
      • Temple, Texas, Spojené státy, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Spojené státy, 84113
        • Primary Children's Hospital
    • Vermont
      • Burlington, Vermont, Spojené státy, 05405
        • University of Vermont and State Agricultural College
    • Virginia
      • Charlottesville, Virginia, Spojené státy, 22908
        • University of Virginia Cancer Center
      • Falls Church, Virginia, Spojené státy, 22042
        • Inova Fairfax Hospital
      • Norfolk, Virginia, Spojené státy, 23507
        • Children's Hospital of The King's Daughters
      • Richmond, Virginia, Spojené státy, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Seattle, Washington, Spojené státy, 98105
        • Seattle Children's Hospital
      • Spokane, Washington, Spojené státy, 99204
        • Providence Sacred Heart Medical Center and Children's Hospital
      • Tacoma, Washington, Spojené státy, 98405
        • Mary Bridge Children's Hospital and Health Center
      • Tacoma, Washington, Spojené státy, 98431
        • Madigan Army Medical Center
    • West Virginia
      • Charleston, West Virginia, Spojené státy, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Spojené státy, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Green Bay, Wisconsin, Spojené státy, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Madison, Wisconsin, Spojené státy, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marshfield, Wisconsin, Spojené státy, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Spojené státy, 53226
        • Children's Hospital of Wisconsin

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

2 roky až 22 let (Dítě, Dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • Patients with newly diagnosed, pathologically confirmed cHL meeting one of the following Ann Arbor stages are eligible:

    • Stage IIB with bulk

    • Stage IIIB

    • Stage IVA

    • Stage IVB

      • If study eligibility by staging is uncertain, consultation with Imaging and Radiation Oncology Core (IROC) Rhode Island (RI) may be obtained prior to study enrollment
  • Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows (performed within 14 days prior to enrollment):

    • 2 to < 6 years: male 0.8 mg/dL, female 0.8 mg/dL
    • 6 to < 10 years: male 1 mg/dL, female 1 mg/dL
    • 10 to < 13 years: male 1.2 mg/dL, female 1.2 mg/dL
    • 13 to < 16 years: male 1.5 mg/dL, female 1.4 mg/dL
    • >= 16 years: male 1.7 mg/dL, female 1.4 mg/dL
  • Total bilirubin =< 1.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Serum glutamic oxaloacetic transaminase (SGOT) (aspartate transaminase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine transaminase [ALT]) < 2.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Shortening fraction of >= 27% by echocardiogram, or ejection fraction of >= 50% by radionuclide angiogram

  • Forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) > 60% by pulmonary function test (PFT), unless due to large mediastinal mass from Hodgkin lymphoma (HL)

  • For children who are unable to cooperate for PFTs, the criteria are: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry reading of > 92% on room air

  • All patients and/or their parents or legal guardians must sign a written informed consent

  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria:

  • Patients with nodular lymphocyte-predominant HL
  • Patients with an immunodeficiency that existed prior to diagnosis, such as primary immunodeficiency syndromes, organ transplant recipients and children on current systemic immunosuppressive agents are not eligible
  • Patients who are pregnant; (since fetal toxicities and teratogenic effects have been noted for several of the study drugs, a negative pregnancy test is required for female patients of childbearing potential)
  • Lactating females who plan to breastfeed
  • Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation and for 30 days after the last dose of chemotherapy
  • Patients known to be positive for human immunodeficiency virus (HIV) are not eligible
  • Patients who have received any previous chemotherapy or radiation therapy are not eligible
  • Patients who received systemic corticosteroids within 28 days of enrollment on this protocol, except as specified, are not eligible

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Aktivní komparátor: Arm I (ABVE-PC)

Patients receive doxorubicin hydrochloride IV over on days 1-2, bleomycin sulfate IV or SC on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally PO BID or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Ostatní jména:
  • Hodnocení kvality života

Given IV

Ostatní jména:
  • Cytoxan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oxazafosforin, 2-[bis(2-chlorethyl)amino]tetrahydro-,2-oxid, monohydrát
  • Carloxan
  • Cyklofosfamida
  • Cyklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrát
  • CYCLO-buňka
  • Cykloblastin
  • Cyklofosfam
  • Monohydrát cyklofosfamidu
  • Cyklofosfamid monohydrát
  • Cyklofosfamidum
  • Cyklofosfan
  • Cyklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxální
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimunitní
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B 518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Ostatní jména:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoxy-alfa-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(hydroxyacetyl)-1-methoxy-, hydrochlorid, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin hydrochlorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • FI106

Given PO

Ostatní jména:
  • Deltasone
  • Orasone
  • Delta 1-kortizon
  • 1,2-dehydrokortison
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Dekortisyl
  • Decorton
  • Delta-Dome
  • Deltacortene
  • Deltakortizon
  • Deltadehydrokortison
  • Deltison
  • Deltra
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metakortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Paracort
  • Perrigo Prednison
  • PRED
  • Predicor
  • Predicorten
  • Přednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Rayos
  • Servisone
  • SK-Prednison

Given IV

Ostatní jména:
  • Oncovin
  • Kyocristine
  • Leurokristin sulfát
  • Leurokristin, sulfát
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfát

Ancillary studies

Given IV

Ostatní jména:
  • Demethyl epipodofylotoxin Ethylidin glukosid
  • EPEG
  • Lastet
  • Toposar
  • Vepesid
  • VP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV or SC

Ostatní jména:
  • Bleocin
  • Blenoxan
  • Blanoxan
  • BleMomycine
  • Bleo-buňka
  • Bleo-S
  • Bleolem
  • Bleomycin Sulfas
  • Bleomycin sulfát
  • Bleomycini Sulfas
  • Blexane
  • Olej Bleo

Given IV

Ostatní jména:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depo Moderin
  • Depo-Nisolone
  • Duralone
  • Emmetipi
  • Esametone
  • Firmacort
  • Medlone 21
  • Medrate
  • Medrol Veriderm
  • Medrone
  • Mega-Star
  • Meprolon
  • Methylprednisolonum
  • Metilbetason rozpustný
  • Metrocort
  • Metypresol
  • Metysolon
  • Předni-M-Tablinen
  • Přednilen
  • Radilem
  • Sieropresol
  • Solpredone
  • Summicort
  • Urbason
  • Veriderm Medrol
Experimentální: ARM II (Bv-AVEPC)

Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Ostatní jména:
  • Hodnocení kvality života

Given IV

Ostatní jména:
  • Cytoxan
  • CTX
  • (-)-cyklofosfamid
  • 2H-1,3,2-oxazafosforin, 2-[bis(2-chlorethyl)amino]tetrahydro-,2-oxid, monohydrát
  • Carloxan
  • Cyklofosfamida
  • Cyklofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrát
  • CYCLO-buňka
  • Cykloblastin
  • Cyklofosfam
  • Monohydrát cyklofosfamidu
  • Cyklofosfamid monohydrát
  • Cyklofosfamidum
  • Cyklofosfan
  • Cyklostin
  • Cytofosfan
  • Fosfaseron
  • Genoxal
  • Genuxální
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimunitní
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B 518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Ostatní jména:
  • Adriamycin
  • 5,12-naftacendion, 10-[(3-amino-2,3,6-trideoxy-alfa-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(hydroxyacetyl)-1-methoxy-, hydrochlorid, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin hydrochlorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
  • FI106

Given PO

Ostatní jména:
  • Deltasone
  • Orasone
  • Delta 1-kortizon
  • 1,2-dehydrokortison
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Dekortisyl
  • Decorton
  • Delta-Dome
  • Deltacortene
  • Deltakortizon
  • Deltadehydrokortison
  • Deltison
  • Deltra
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metakortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Paracort
  • Perrigo Prednison
  • PRED
  • Predicor
  • Predicorten
  • Přednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Rayos
  • Servisone
  • SK-Prednison

Given IV

Ostatní jména:
  • Oncovin
  • Kyocristine
  • Leurokristin sulfát
  • Leurokristin, sulfát
  • Vincasar
  • Vincosid
  • Vincrex
  • Vinkristin, sulfát

Ancillary studies

Given IV

Ostatní jména:
  • Adcetris
  • SGN-35
  • cAC10-vcMMAE
  • ADC SGN-35
  • Konjugát anti-CD30 protilátka-lék SGN-35
  • Monoklonální protilátka proti CD30-MMAE SGN-35
  • Monoklonální protilátka anti-CD30-monomethylauristatin E SGN-35
  • SGN35
  • SGN 35

Given IV

Ostatní jména:
  • Demethyl epipodofylotoxin Ethylidin glukosid
  • EPEG
  • Lastet
  • Toposar
  • Vepesid
  • VP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV

Ostatní jména:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depo Moderin
  • Depo-Nisolone
  • Duralone
  • Emmetipi
  • Esametone
  • Firmacort
  • Medlone 21
  • Medrate
  • Medrol Veriderm
  • Medrone
  • Mega-Star
  • Meprolon
  • Methylprednisolonum
  • Metilbetason rozpustný
  • Metrocort
  • Metypresol
  • Metysolon
  • Předni-M-Tablinen
  • Přednilen
  • Radilem
  • Sieropresol
  • Solpredone
  • Summicort
  • Urbason
  • Veriderm Medrol

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Event Free Survival (EFS), Where Events Include Disease Progression or Relapse, Second Malignancy, or Death
Časové okno: Up to 48 months after the last enrollment

Primary analysis will be based 1-sided log rank test comparison of EFS curves between the 2 randomized arms per intention-to-treat principle. Progression is defined as an ≥50% increase of in the product of the perpendicular diameters of any of the involved nodes or nodal masses or focal organ lesions in sites that were persistently PET positive; or recurrent PET positive lesions (Deauville 4, 5) in sites that had previously been PET negative regardless of change of size, as was the development of new PET avid measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Relapse is defined in patients who achieved a prior CR but subsequently has an increase of ≥50% of the PPD in prior nodal or extranodal sites in a recurrently PET positive lesion(s), or the development of new measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Second malignancy is defined based on report of a cancer that is not considered to be classic Hodgkin Lymphoma.

Up to 48 months after the last enrollment

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Percentages of Patients With Early Response Defined as no Slow Responding Lesions (SRL) and no Progressive Disease (PD) at Any Disease Sites Determined by Positron Emission Tomography (PET) Per Deauville Criteria Through Central Review
Časové okno: After 42 days of chemotherapy

The percentages of patients (with available PET scan) with no SRL and no PD will be compared between the two randomized arms to see if brentuximab vedotin in the chemotherapy backbone of doxorubicin hydrochloride, vincristine sulfate, etoposide, prednisone and cyclophosphamide (Bv-AVEPC) arm has a higher rate of early response compared to doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC) arm. Two-sample Z test of proportions at 1-sided alpha level of 0.05 will be used for these comparisons.

After 42 days of chemotherapy
Percentages of Patients Experiencing Grade 3+ Peripheral Neuropathy Assessed by Modified Balis Scale
Časové okno: From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

The percentages of patients experiencing grade 3+ peripheral neuropathy assessed by the treating clinician using the modified Balis scale. The "Modified Balis scale of Pediatric Neuropathy" allows clinicians to assign a score for sensory or motor neuropathy symptoms separately. Scores range from 1 to 4 with 1 being the least symptomatic state and 4 indicating a severe debility. The percentages of patients (with a score >/=3) will be compared between the 2 arms by two-sample Z test at 1-sided alpha level of 0.05.

From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

Další výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Childhood International Prognostic Score (CHIPS) Score
Časové okno: Baseline

CHIPS will be computed for all patients and summarized by descriptive statistics. Will examine the association between CHIPS and early response by cross-tabulations and Chi-square tests within each arm separately, as well as logistic regression model where early response is the outcome variable and CHIPS the predictor variable combining the 2 arms with adjustment for randomized chemotherapy.

Baseline
Dose of Radiation Received by Normal Tissues Following Chemotherapy on Either Study Arm
Časové okno: Up to 48 months

Descriptive statistics will be used to summarize RT doses received by normal tissues on this study. Two-sample t-test will be used to compare the doses received on this study to those on prior studies.

Up to 48 months
Efficacy of Involved Site Radiotherapy (ISRT) by Analyzing the Event-free Survival of Patients Treated With Response-adapted ISRT and by Evaluating Patterns of Relapse Following ISRT
Časové okno: Up to 3 years

EFS for patients on each arm as well as those receiving ISRT or those with slow early response (SER) on each arm will be estimated. One-sample log rank test will be used to compare the observed EFS to the assumed baseline of 82% at 3 years to see if the observed EFS is significantly lower than the projection in these subsets.

Up to 3 years
Risk of Relapse Among RRL Subjects That Have at Least One Lesion That is Deauville 3 at PET 2
Časové okno: Up to 48 months after the last enrollment

The risk of relapse for cases that are RRL, but have Deauville 3 lesions, will be compared to those that are classified as complete metabolic response at PET2 with solely Deauville 1 or 2 lesions with K-sample test.

Up to 48 months after the last enrollment
Pharmacokinetic (PK) Analyses
Časové okno: Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

PK concentration time profile will be evaluated.

Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Vrchní vyšetřovatel: Sharon M Castellino, Children's Oncology Group

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

19. března 2015

Primární dokončení (Aktuální)

31. prosince 2021

Dokončení studie (Odhadovaný)

14. října 2027

Termíny zápisu do studia

První předloženo

16. června 2014

První předloženo, které splnilo kritéria kontroly kvality

16. června 2014

První zveřejněno (Odhadovaný)

18. června 2014

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

13. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

10. listopadu 2026

Naposledy ověřeno

1. června 2026

Více informací

Termíny související s touto studií

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit